It should mean a jump in value of something resembling whatever the discount is. Also, Invesco is a pretty good fund company, so OK on that score, though it layed an egg last year wrt GHS. Now the fund is under new management, so we'll see. The open ending, BTW, is probably a quid pro quo for getting the new management.OTOH, the fund will now have to keep a cash reserve against redemptions, which could be heavy at first with people cashing out.Bottom line: probably good short term, but you'll need to reevaluate how you invest in Health Sciences. Consider Janus for a managed fund, or get an index fund based on the S&P 500, which the Fool talks about somewhere.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Ma